HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Cervical labor induction with prostaglandin E2 in patients with fetal death].

Abstract
The objective was to compare the effectiveness and efficacy of prostaglandin E2 (prepidil gel) plus oxitocin with that of intravenous oxitocin in the treatment of delivery induction in patients complicated with fetal death. Fifteen patients received prepidil gel plus oxitocin and 15 patients oxitocin. In the treatment group only one dosage of 0.5 ng in 2 ml of prepidil gel was administered intracervically and simultaneously oxitocin by intravenous infusion, dosage was increased 2 mUI/min every 30 minutes. In the control group only intravenous oxitocin was administered at the same dosage. The mean duration in hours of delivery in the treatment group was 13.1 +/- h and in the control group was 30.9 +/- 9.1 h. There were statistically significant differences between the groups in reduction of delivery duration (p = 0.0007). It is concluded that prostaglandin E2 plus oxitocin provide better short-term outcomes than oxitocine treatment and gave more short periods of labor in patients with fetal death.
AuthorsM A Avila-Vergara, F Morgan-Ortiz, O Fragoza-Sosa, L Haro-García
JournalGinecologia y obstetricia de Mexico (Ginecol Obstet Mex) Vol. 65 Pg. 155-8 (Apr 1997) ISSN: 0300-9041 [Print] Mexico
Vernacular TitleMaduración cervical con prostaglandina E2 en pacientes con feto muerto.
PMID9280743 (Publication Type: Clinical Trial, Controlled Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Oxytocics
  • Dinoprostone
Topics
  • Dinoprostone (therapeutic use)
  • Female
  • Fetal Death
  • Humans
  • Labor, Induced
  • Oxytocics (therapeutic use)
  • Pregnancy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: